- FOUNDATION
- |
- IPPE
- |
- PPFC
- |
- CONTACT
News Release
- Media Center Home /
- News Release View


For Immediate Release
U.S. Poultry & Egg Association
Tucker, Ga. - May 11, 2026
- Contact:
- Hannah Keck, 678.514.1979, hkeck@uspoultry.org, (USPOULTRY)
Development of U.S.-Strain Live and Inactivated Vaccines for Control of Avian Metapneumovirus Subtype B in Poultry
USPOULTRY and the USPOULTRY Foundation announce the completion of a research project that developed both live and inactivated vaccine candidates for avian metapneumovirus (aMPV) subtype B. The research is part of the Association’s comprehensive research program, which encompasses all phases of poultry and egg production and processing, and is made possible in part through proceeds from the International Poultry Expo, part of the International Production & Processing Expo.
Project # 745: Development of Live Attenuated and Killed Vaccines for Emerging Avian Metapneumovirus Subgroup B
(Dr. Sunil Kumar Mor, Animal Disease Research and Diagnostic Laboratory, South Dakota State University, Brookings, S.D.)
aMPV, a virus which causes an acute respiratory tract infection in turkeys and chickens, re-emerged in the U.S. poultry industry, rapidly spreading across key poultry-producing states and posing a significant threat to production. The Center for Veterinary Biologics granted conditional approval for imported vaccines based on European strains as an emergency measure in early 2025; however, no licensed live attenuated vaccines derived from U.S. strains are currently available.
A team of researchers, led by Dr. Sunil Mor, at South Dakota University, successfully developed both live and inactivated vaccine candidates for aMPV subtype B. One of the live vaccine candidates showed strong safety and provided complete protection in chickens, while the inactivated vaccine generated strong protective antibody responses. Both vaccine approaches performed well in commercial turkey poults, with the live vaccine offering the highest level of protection.
These results demonstrate strong potential for practical, field-ready tools to help control aMPV in poultry. Overall, the work supports the development of U.S.-based vaccines to reduce future disease impacts and economic losses in the poultry industry.
The research summary can be found on the USPOULTRY website. Information on other Association research may also be obtained by visiting the USPOULTRY website.
###
More Recent News
July 16, 2026
2026 USPOULTRY Financial Management Seminar Explores Leadership, Market Dynamics and the Future of Animal Protein
Finance professionals from across the poultry and egg industry gathered at the 2026 USPOULTRY Financial Management Seminar to gain insights into the leadership, economic and market trends shapin...
![]()
July 15, 2026
New Research Provides Insights to Improve Broiler Breeder Fertility and Chick Output
Broiler breeder flock social dynamics may play a much greater role in reproductive success than previously recognized, according to new research funded by USPOULTRY and the USPOULTRY Foundation. T...
July 14, 2026
2027 USPOULTRY Family Farm Environmental Excellence Award Open for Nominations
The U.S. Poultry & Egg Association (USPOULTRY) is now accepting nominations for the 2027 Family Farm Environmental Excellence Award. This award recognizes family farmers who demonstrate exc...
General Info
Events & Meetings
People & Groups
- Affiliated States
- Air Cargo Committee
- Hen Council
- Industry Partners
- Poultry Protein & Fat Council
- USPOULTRY Foundation